DarioHealthDRIO +1.17%62 EV-to-FCF is -2.21 as of Jun. 24, 2026. GuruFocus rates DRIO with a GF Score™ of 62/100 and a GF Value™ of $7.16 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 410 Healthcare Providers & Services companies, DarioHealth ranks worse than 243902.2% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, DarioHealth's Enterprise Value is $56.12 Mil.
DarioHealth's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-25.44 Mil. Therefore, DarioHealth's EV-to-FCF for today is -2.21.
The historical rank and industry rank for DarioHealth's EV-to-FCF or its related term are showing as below:
DRIO'
s EV-to-FCF Range Over the Past 10 Years
Min: -12.26 Med: -1.52 Max: 0.78
Current: -2.21
During the past 13 years, the highest EV-to-FCF of DarioHealth was 0.78. The lowest was -12.26. And the median was -1.52.
DRIO's EV-to-FCF is ranked worse than 100% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.47
vs DRIO: -2.21
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
DarioHealth's PE Ratio (TTM) for today is calculated as:
DarioHealth's share price for today is $6.06.
DarioHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.295.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
DarioHealth EV-to-FCF Related Terms
DarioHealth EV-to-FCF Historical Data
* Premium members only.
The historical data trend for DarioHealth's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, DarioHealth's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DarioHealth EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where DarioHealth's EV-to-FCF falls into.
DarioHealth's current Enterprise Value is $56.12 Mil.
DarioHealth's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DarioHealth (DRIO) has a EV-to-FCF of -2.21 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on DarioHealth and its competitors. According to the industry distribution chart, DarioHealth ranks #999999 out of 410 companies in the Healthcare Providers & Services industry.
Is DarioHealth's EV-to-FCF too high?
DarioHealth's current EV-to-FCF is -2.21. Based on the distribution chart, DarioHealth ranks #999999 out of 410 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, DarioHealth has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's EV-to-FCF compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #999999 out of 410 companies for EV-to-FCF. This places DarioHealth in the lower half of its industry. The industry median EV-to-FCF is 17.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.47, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on DarioHealth and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DarioHealth's current EV-to-FCF is -2.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.16, compared to a current price of $6.06 — trading 15.4% below its estimated fair value. The current EV-to-FCF is -2.21. DarioHealth's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For DarioHealth (DRIO), the current EV-to-FCF is -2.21 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DarioHealth (DRIO) Overvalued in 2026?
Based on GuruFocus' analysis, DarioHealth stock appears to be undervalued.
The current stock price of $6.06 is trading 15.4% below its estimated GF Value™ of $7.16.
GuruFocus considers DarioHealth to be Modestly Undervalued.
Key valuation signals for DRIO:
EV-to-FCF: -2.21
GF Value™: $7.16 vs. price of $6.06 (15.4% below fair value)
No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
62GF Score
Get the complete analysis for DRIO
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRIO has been successfully added to your 
